The Covid-19 pandemic will challenge US dietary supplement manufacturers to remain compliant with good manufacturing practices as ingredient supplies become more difficult to acquire and costs increase as they turn to new suppliers, say regulatory consultants.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?